IP Library Granted Patent US 9,089,582
Granted Patent B2
US 9,089,582 · App. 12/951,581 · Granted Jul 28, 2015

Stabilization of vitamin B

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,089,582
App. No.
12/951,581
Granted
Jul 28, 2015
Kind
B2
Abstract

The invention relates to preparations comprising vitamin B 12 and a butanol, and to the use of butanol for stabilizing vitamins.

Claims (15)

1. A method of stabilizing a vitamin B12 formulation to light, the method comprising:

dissolving an amount of vitamin B12 in water by heating to form a vitamin B12 solution,

mixing the vitamin B12 solution with butaphosphan and n-butanol to form a stock solution, and

adjusting the stock solution to a pH of from about 4 to about 7 by adding an acid or a base to form the vitamin B12 formulation, wherein the vitamin B12 formulation comprises from 0.001 to 0.01% m/V vitamin B12 and from 0.5 to 7% m/V n-butanol.

2. The method of claim 1 , wherein the vitamin B12 formulation comprises from 1 to 30% m/V butaphosphan.

3. The method of claim 1 , wherein the vitamin B12 formulation comprises from 0.001 to 10% m/V acid or base.

4. The method of claim 1 , wherein the vitamin B12 formulation further comprises a cosolvent.

5. The method of claim 1 , wherein the vitamin B12 formulation further comprises an antioxidant, wetting agent, or combinations thereof.

6. The method of claim 1 wherein the pH of the stock solution is adjusted to 5.6±0.2 by adding an acid or a base.

7. The method of claim 1 wherein the vitamin B12 formulation comprises from 0.005 to 0.01% m/V vitamin B12.

8. The method of claim 1 wherein the vitamin B12 formulation comprises from 0.0075 to 0.01% m/V vitamin B12.

9. The method of claim 1 wherein the vitamin B12 formulation comprises from 1 to 5% m/V n-butanol.

10. The method of claim 1 wherein the vitamin B12 formulation comprises from 2 to 4% m/V n-butanol.

11. The method of claim 1 further comprising sterilizing the vitamin B12 formulation.

12. The method of claim 1 wherein vitamin B12 is cyanocobalamin.

Assignments (3)
CHANGE OF NAME Recorded Feb 8, 2024
From: BAYER ANIMAL HEALTH GMBH
To: ELANCO ANIMAL HEALTH GMBH
Reel/Frame 066525/0898 →
NUNC PRO TUNC ASSIGNMENT Recorded Feb 7, 2024
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER ANIMAL HEALTH GMBH
Reel/Frame 066401/0955 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2013
From: BAYER ANIMAL HEALTH GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030127/0549 →